leadf
logo-loader
viewMetal Tiger PLC

Metal Tiger invests a further A$86,000 in gold explorer Los Cerros Ltd

Metal Tiger has a long track record of successfully investing in the mining sector

Metal Tiger PLC -

Metal Tiger PLC (LON:MTR) has subscribed for 750,000 shares in Los Cerros Ltd (ASX:LCL) at A$0.115 per share, for a total investment of A$86,000 as part of a Los Cerros' fundraise of A$10mln.

This is a follow-on investment to Metal Tiger's initial investment in Los Cerros in early 2020. 

The Los Cerros share price has increased 400% since Metal Tiger's initial investment, based on the latest closing share price.

Following completion of the raise, Metal Tiger's holdings in Los Cerros will consist of 3.9mln shares representing approximately 0.9% of Los Cerros, and 1.25mln warrants exercisable at A$0.10.

Los Cerros' primary focus is the Quinchia gold portfolio, which is located in Colombia's Mid-Cauca belt. The 10,500 hectare Quinchia project contains a number of gold deposits and significant exploration and development targets, including Miraflores, Tesorito, Chuscal and Dosquebrada.

Quick facts: Metal Tiger PLC

Price: 24.55 GBX

AIM:MTR
Market: AIM
Market Cap: £37.62 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Metal Tiger PLC named herein, including the promotion by the Company of Metal Tiger PLC in any Content on the Site, the Company receives from...

FOR OUR FULL DISCLAIMER CLICK HERE

Morning report: FTSE falls as traders get back to their desks

The FTSE is lower after a long weekend despite UK factory output rising by the fastest pace in more than six years, albeit from a low level as businesses begin to get back to work.  Movers and shakers include AstraZeneca (LON:AZN) which has received EU approval for Imfinzi which is to...

2 weeks, 6 days ago

2 min read